MMI

Medical Microinstruments (MMI) develops robotic and digital technologies for microsurgery, with a focus on helping surgeons perform delicate open procedures with greater precision, consistency, and control. Its flagship product, the Symani Surgical System, is designed for microsurgery and supermicrosurgery. The system works with NanoWrist instruments, which feature a small robotic wrist that translates natural hand movements into precise actions for tasks such as dissection and vessel connection.

MMI’s technology supports complex reconstructive procedures across several clinical areas, including lymphedema, breast reconstruction, head and neck cancer, and trauma. The company provides resources for clinicians and hospitals, including training, reimbursement information, case studies, professional presentations, and clinical evidence. It also offers digital solutions and program updates for the medical community.

MMI highlights research reporting outcomes such as improved anastomosis patency and reduced flap loss in certain comparisons with manual techniques. The Symani Surgical System is authorized for use in the United States by the FDA and is CE marked; clinical indications vary by geography. Symani is manufactured in Pisa, Italy.